Patents by Inventor Kevin Hong

Kevin Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110281821
    Abstract: The invention relates to compounds of Formula (I), a polymorph, an enantiomer, a stereoisomer, a solvate, an N-oxide derivative, or a pharmaceutically acceptable salt thereof: Formula (I), which have inhibitory effect on one or more protein kinases that are involved in cell mitosis.
    Type: Application
    Filed: January 30, 2008
    Publication date: November 17, 2011
    Applicant: Biogen Idec MA Inc.
    Inventors: Srinivas Rao Kasibhatla, Kevin Hong, Lin Zhang, Marcus F. Boehm, Junhua Fan, Jean-Yves LeBrazidec
  • Publication number: 20100249067
    Abstract: The invention relates to compounds of Formula (I), a polymorph, an enantiomer, a stereoisomer, a solvate, an N-oxide derivative, or a pharmaceutically acceptable salt thereof: Formula (I), which have inhibitory effect on one or more protein kinases that are involved in cell mitosis.
    Type: Application
    Filed: January 30, 2008
    Publication date: September 30, 2010
    Applicant: Biogen Idec MA Inc.
    Inventors: Srinivas Rao Kasibhatla, Kevin Hong, Lin Zhang, Marcus F. Boehm, Junhua Fan, Jean-Yves LeBrazidec
  • Publication number: 20100190787
    Abstract: The invention relates to compounds of Formula (I), a prodrug, a polymorph, a tautomer, an enantiomer, a stereoisomer, a solvate, an N-oxide, or a pharmaceutically acceptable salt thereof: (formula should be inserted here) which have inhibitory effect on one or more protein kinases that are involved in cell mitosis.
    Type: Application
    Filed: January 30, 2008
    Publication date: July 29, 2010
    Inventors: Srinivas Rao Kasibhatla, Kevin Hong, Lin Zhang, Marcus F. Boehm, Junhua Fan, Jean-Yves LeBrazidec
  • Patent number: 7584905
    Abstract: Efficient fuel combustion catalyst delivery device and method are provided. A fuel combustion catalyst delivery device includes a storage vessel that contains a liquid. The liquid includes one or more catalytic materials. The storage vessel is attached to a nebulizer that can convert the liquid to an aerosol to be delivered into an air intake of a combustion zone. The aerosol can accelerate fuel combustion. The storage vessel and the nebulizer are made from materials suitable to be exposed to the liquid and the aerosol. The storage vessel and the nebulizer are also suitable to be placed in proximity to the combustion zone such as an engine compartment so that the aerosol can be delivered into the air intake of the combustion zone easily and effectively. The surfaces of the delivery device exposed to the liquid or the aerosol may be made of corrosion-resistant or inert materials if the liquid is acidic.
    Type: Grant
    Filed: November 7, 2005
    Date of Patent: September 8, 2009
    Assignee: Emissions Technology, Inc.
    Inventors: Emmett Manuel Cunningham, George M. Malouf, Russ Webster, Kevin Hong, Xiong Pei Li
  • Publication number: 20080125446
    Abstract: Novel purine compounds and tautomers and pharmaceutically acceptable salts thereof are described, as are pharmaceutical compositions comprising the same, complexes comprising the same, e.g., HSP90 complexes, and methods of using the same.
    Type: Application
    Filed: July 2, 2007
    Publication date: May 29, 2008
    Inventors: Srinivas Rao Kasibhatla, Kevin Hong, Lin Zhang, Marco Antonio Biamonte, Marcus F. Boehm, Jiandong Shi, Junhua Fan
  • Publication number: 20080065792
    Abstract: A system and method for custom branding a host application executed on a host device. The host device couples with an accessory device, where a host application is provided for managing/controlling the accessory device. During run time, i.e., when the accessory device is coupled with the host device, the host device can retrieve at least one resource object in which graphical user interface elements associated with the accessory device type have been encoded or preconfigured. The host device can then render the host application with the graphical user interface elements, effectively custom branding the host application.
    Type: Application
    Filed: September 7, 2006
    Publication date: March 13, 2008
    Inventors: John Jun Wu, Thanh Khai Ong, Kevin Hong Ho
  • Publication number: 20070185064
    Abstract: 2-Aminopurine analogs are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 12, 2006
    Publication date: August 9, 2007
    Applicant: Conforma Therapeutics Corporation
    Inventors: Srinivas Kasibhatla, Kevin Hong, Marcus Boehm, Marco Biamonte, Lin Zhang
  • Publication number: 20070173483
    Abstract: Pyrrolopyrimidines and related analogs are described and demonstrated to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents used in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Methods of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 12, 2006
    Publication date: July 26, 2007
    Applicant: Conforma Therapeutics Corporation
    Inventors: Srinivas Kasibhatla, Jiandong Shi, Jean-Yves Le Brazidec, Marco Biamonte, Kevin Hong, Marcus Boehm
  • Patent number: 7241890
    Abstract: Novel purine compounds of Formula I. and tautomers, pharmaceutically acceptable salts, and prodrugs thereof, wherein X is S, S(O), or S(O)2; and O is selected from alkyl, cycloalkyl, arylalkyl, aryl, heteroaryl, and heterocyclic, all optionally substituted, are described, as are pharmaceutical compositions comprising the same, complexes comprising the same, e.g., HSP90 complexes, and methods of using the same.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: July 10, 2007
    Assignee: Conforma Therapeutics Corporation
    Inventors: Srinivas Rao Kasibhatla, Kevin Hong, Lin Zhang, Marco Antonio Biamonte, Marcus F. Boehm, Jiandong Shi, Junhua Fan
  • Publication number: 20070129334
    Abstract: Novel purine compounds and tautomers and pharmaceutically acceptable salts thereof are described, as are pharmaceutical compositions comprising the same, complexes comprising the same, e.g., HSP90 complexes, and methods of using the same. Methods of using the novel purine compounds of the invention, and tautomers and pharmaceutically acceptable salts thereof, include their use in inhibiting heat shock protein 90's (HSP90's) to thereby treat or prevent HSP90-dependent diseases, e.g., proliferative disorders such as breast cancer.
    Type: Application
    Filed: December 18, 2006
    Publication date: June 7, 2007
    Applicant: CONFORMA THERAPEUTICS CORPORATION
    Inventors: Srinivas Kasibhatla, Lin Zhang, Marco Biamonte, Marcus Boehm, Junhua Fan, Jiandong Shi, Kevin Hong
  • Publication number: 20070111996
    Abstract: Pyrazolopyrimidines and related analogs are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 29, 2006
    Publication date: May 17, 2007
    Applicant: Conforma Therapeutics Corporation
    Inventors: Srinivas Kasibhatla, Marco Biamonte, Kevin Hong, David Hurst, Marcus Boehm
  • Publication number: 20070111997
    Abstract: Triazolopyrimidines and related compounds are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 29, 2006
    Publication date: May 17, 2007
    Applicant: Conforma Therapeutics Corporation
    Inventors: Srinivas Kasibhatla, Kevin Hong, Marcus Boehm
  • Publication number: 20060112906
    Abstract: Efficient fuel combustion catalyst delivery device and method are provided. A fuel combustion catalyst delivery device includes a storage vessel that contains a liquid. The liquid includes one or more catalytic materials. The storage vessel is attached to a nebulizer that can convert the liquid to an aerosol to be delivered into an air intake of a combustion zone. The aerosol can accelerate fuel combustion. The storage vessel and the nebulizer are made from materials suitable to be exposed to the liquid and the aerosol. The storage vessel and the nebulizer are also suitable to be placed in proximity to the combustion zone such as an engine compartment so that the aerosol can be delivered into the air intake of the combustion zone easily and effectively. The surfaces of the delivery device exposed to the liquid or the aerosol may be made of corrosion-resistant or inert materials if the liquid is acidic.
    Type: Application
    Filed: November 7, 2005
    Publication date: June 1, 2006
    Applicant: Emissions Technology, Inc.
    Inventors: Emmett Cunningham, George Malouf, Russ Webster, Kevin Hong, Xiong Li
  • Publication number: 20050119282
    Abstract: Pyrazolopyrimidines and related analogs are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 20, 2004
    Publication date: June 2, 2005
    Inventors: Srinivas Kasibhatla, Marco Biamonte, Kevin Hong, David Hurst, Marcus Boehm
  • Publication number: 20050113340
    Abstract: 2-Aminopurine analogs are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 20, 2004
    Publication date: May 26, 2005
    Inventors: Srinivas Kasibhatla, Kevin Hong, Marcus Boehm, Marco Biamonte, Lin Zhang
  • Publication number: 20050113339
    Abstract: Triazolopyrimidines and related compounds are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 20, 2004
    Publication date: May 26, 2005
    Inventors: Srinivas Kasibhatla, Kevin Hong, Marcus Boehm
  • Publication number: 20050107343
    Abstract: Pyrrolopyrimidines and related analogs are described and demonstrated to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents used in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Methods of synthesis and use of such compounds are also described and claimed.
    Type: Application
    Filed: September 20, 2004
    Publication date: May 19, 2005
    Inventors: Srinivas Kasibhatla, Jiandong Shi, Jean-Yves Le Brazidec, Marco Biamonte, Kevin Hong, Marcus Boehm
  • Publication number: 20050049263
    Abstract: Novel purine compounds and tautomers and pharmaceutically acceptable salts thereof are described, as are pharmaceutical compositions comprising the same, complexes comprising the same, e.g., HSP90 complexes, and methods of using the same.
    Type: Application
    Filed: October 30, 2002
    Publication date: March 3, 2005
    Inventors: Srinivas Kasibhatla, Kevin Hong, Lin Zhang, Marco Biamonte, Marcus Boehm, Jiandong Shi, Junhua Fan
  • Patent number: 6563821
    Abstract: A remote communications server system enables multiple remote users simultaneous access to a network through a segmented design that distributes the processing of the connections among a combination of buses and processors. The system coordinates a plurality of independent communications links bonded together into a single channel to create a virtual connection to the network having a bandwidth greater than the individual links. The system supports a mixture of physical and multiplexed communication links and allows the intermixing of different types of links in a bonded channel. The system is scalable in that segments can be added as needed and the number of lines handled by a segment can be increased.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: May 13, 2003
    Assignee: Multi-Tech Systems, Inc.
    Inventors: Kevin Hong, Damodar Bhat, Narasimhan Sundarraajan, Satish Mugulavalli
  • Patent number: H2065
    Abstract: A proxy server shares a plurality of modems connected to a wide area network among multiple client computers connected to a local area network. Each of the client computers on the local area network is assigned a local address while each of the plurality of modems is assigned a modem port address valid on the wide area network. In one embodiment, a processor controls address substitution allowing multiple client computers to share modems when communicating to host computers in a wide area network. The processor creates a descriptor list to keep track of the connections between the client computer and host computers on the wide area network and uses the descriptor list to determine to which client computer an incoming data packet should be sent. The processor also creates a proxied application list to determine if an outgoing data packet, received from one of the client computers, is one to be proxied through the proxy server.
    Type: Grant
    Filed: December 28, 1998
    Date of Patent: May 6, 2003
    Assignee: Multi-Tech Systems, Inc.
    Inventors: Kevin Hong, Vidyasagaran Parameswaran Nair